Namouni Fouad - Insider Non-Derivative Transactions at Blueprint Medicines Corp (BPMC) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jul 17, 2025, Namouni Fouad's relationship to Blueprint Medicines Corp (BPMC) is Officer (PRESIDENT, R & D), and currently has 115,237 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BPMC insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Namouni Fouad - Insider Non-Derivative Transactions of BPMC Common Stock

Namouni Fouad - Insider Non-Derivative Transactions at BPMC

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jul 18, 2025	U -- (Common Stock)	31956	0	0
Jul 18, 2025	Disposition -- (Common Stock)	83281	0	31956
Jul 18, 2025	Acquisition -- (Common Stock)	39456	0	115237
Mar 6, 2025	Sell -- (Common Stock)	6489	88.8	75781
Mar 2, 2025	Acquisition -- (Common Stock)	13200	0	82270
Oct 4, 2024	Sell -- (Common Stock)	3633	89.32	69070
Mar 8, 2024	Sell -- (Common Stock)	4377	90.69	72703
Mar 2, 2024	Acquisition -- (Common Stock)	15000	0	77080
Oct 5, 2023	Sell -- (Common Stock)	3769	48.06	62080
Mar 7, 2023	Sell -- (Common Stock)	63	44.36	65849
Mar 7, 2023	Sell -- (Common Stock)	1885	45.72	65912
Mar 2, 2023	Acquisition -- (Common Stock)	15000	0	67797